Evidence map›Paper›PMID 33556344›Full record

ArticleJournal of immunological methods2021

Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells.

Naoki Tanimine, Bryna E Burrell, Kevin Deng, Charles Rickert, Kang Mi Lee, Noel Feeney, Jorge Pardo, Christian LeGuern, James F Markmann

Open access · greenAbstract read
In one paragraph

Article in Journal of immunological methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Naoki TanimineCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Bryna E BurrellImmune Tolerance Network, Bethesda, MD, USA.
Kevin DengCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Charles RickertCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Kang Mi LeeCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Noel FeeneyCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Jorge PardoImmune Tolerance Network, Bethesda, MD, USA.
Christian LeGuernCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
James F MarkmannCenter for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Electronic address: jmarkmann@mgh.harvard.edu.
Massachusetts General Hospital · USImmune Tolerance Network · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
NIAID NIH HHS UM1 AI109565
6 · The paper itself

Abstract

Precise analyses of alloreactive T cell phenotype and function can inform both the nature and intensity of adaptive responses to transplant antigens. However, alloreactive T cells are sparse and difficult to detect, particularly in cryopreserved peripheral blood mononuclear cells (PBMCs) and from hypo-responsive individuals. An assay to identify and phenotype alloreactive cells would be particularly valuable, especially for multi-center clinical trials that often store frozen samples for batch analysis. Herein we demonstrate consistent and reproducible alloreactive T cell detection in cryopreserved PBMC following a short-term mixed lymphocyte reaction (MLR). The inherent background expression levels of activation markers on responder T cells were minimized by including a resting period prior to the assay. Stimulator cells were activated before inclusion in the MLR by addition of CD40L and IL-4. The time frame and markers to identify and phenotype alloreactive T cells following stimulation were optimized using short term co-cultures. We defined subsets of CD4+ and CD8+ T cells co-expressing CD69 and either CD154 or CD137 following allostimulation as alloreactive, and further phenotyped these cells with a variety of surface markers such as PD-1, LAG-3, and TIM-3. This assay may allow for the monitoring of donor-specific T cells in transplant recipients with longitudinally collected and cryopreserved PBMCs and provide a useful tool to identify biomarkers associated with tolerance. These biomarkers may add to mechanistic insights in immune recognition of transplanted tissues and/or cells.

Indexed as

Antigens, CDAntigens, Differentiation, T-LymphocyteB-LymphocytesCD40 LigandCD69 AntigensCryopreservationHumansLectins, C-TypeLeukocytes, MononuclearLymphocyte ActivationLymphocyte Culture Test, MixedT-LymphocytesTumor Necrosis Factor Receptor Superfamily, Member 9Antigens, CDAntigens, Differentiation, T-LymphocyteCD40 LigandCD69 AntigensLectins, C-TypeTNFRSF9 protein, humanTumor Necrosis Factor Receptor Superfamily, Member 9Alloreactive T cellsCD137CD154Peripheral blood mononuclear cellTransplantation

Identifiers

PMID33556344
PMCPMC12416544
OpenAlexW3126522752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.